Background
Urinary tract infections (UTI) in pregnancy are a large and under-emphasized risk factor for pregnancy morbidity and adverse birth outcomes in low- and middle-income country (LMIC) settings [
1]. UTI may present in pregnancy with symptoms of acute cystitis or pyelonephritis, or may be more insidious in women with asymptomatic bacteriuria (ASB). Screening and treatment of ASB by urine culture is recommended for all women at least once in early pregnancy in high-income countries, by the Infectious Diseases Society of America [
2], Canadian Task Force on Preventive Care [
3], and National Institute of Health and Clinical Excellence of the United Kingdom (UK) [
4]. In low-income countries, screening and treatment of UTI or ASB is challenging due to the costs and logistics of performing urine culture. Recently, the World Health Organization (WHO) made context-specific antenatal care recommendations for screening and treatment of ASB in LMIC [
5], recommending urine culture in settings with capacity, or mid-stream urine Gram stain, and treatment of ASB.
There is a paucity of population-based data on the prevalence and etiology of UTI in pregnancy in low-middle income countries. In a recent review, the global prevalence of UTI and/or ASB in pregnancy ranged from 3 to 35% across 5 continents in countries with preterm birth rates > 10% [
1]. Women carry higher risk of UTI than men, and pregnancy places women at increased risk of ascending infection due to the weight of the fetus and dilation of the ureters and renal pelvis [
6,
7]. Before urine culture was standard of care in the US (1960’s), pyelonephritis developed in 40% of pregnant women with untreated bacteriuria [
8]. Maternal urinary tract infections may trigger an inflammatory response, including the release of chemokines and cytokines that may result in decidual activation, prostaglandin release, and cervical ripening, thereby increasing the risk of preterm birth [
9]. In historical studies, approximately 30–50% of women with pyelonephritis delivered preterm [
10‐
12]. ASB is significantly associated with preterm delivery (RR 2·00, 95% CI 1·43–2·77) [
13], and low birthweight (RR 1.54, 95% CI 1.35–1.75); however, evidence for the impact of ASB screening and treatment on preterm birth risk has been graded as weak [
14]. In addition, maternal UTI has been associated with increased risk of stillbirth [
15] and early onset neonatal sepsis [
16].
We recently screened pregnant women for UTI as part of a cluster-randomized controlled trial (clinicaltrials.gov identifier: NCT01572532) designed to evaluate the impact of a community-based antenatal screening and treatment program for genito-urinary tract infections in early pregnancy on population-level rates of preterm birth in rural Sylhet district, Bangladesh [
17,
18]. In this manuscript, we describe the population-based prevalence, risk factors, etiology, and antimicrobial resistance patterns of UTIs in this cohort.
Discussion
In a cohort of pregnant women in rural Sylhet, Bangladesh, the prevalence of UTI in early pregnancy was 8.9% (4.4% symptomatic UTI, 4.5% asymptomatic bacteriuria). A majority of women with bacteriuria in pregnancy were asymptomatic. Risk factors for UTI in this population included maternal undernutrition, primiparity, and low paternal education. The common uro-pathogens were similar to those reported in other geographies, with a predominance of gram negatives, including E. coli and Klebsiella, as well as staphyloccocal species. Group B streptococcus accounted for only 5.3% of uro-pathogens. Rates of antibiotic resistance were high, with greater than 30% of E. coli resistant to 3rd generation cephalosporins.
The prevalence of UTI/ASB in our study population was comparable to other studies in South Asia. In our study, we sampled all pregnant women identified from households in the study catchment area. This differs from the majority of studies, which recruited pregnant women presenting at ANC clinics or tertiary care facilities. One Bangladeshi study recruiting from ANC clinics reported a 5% bacteriuria rate, with 1% of women presenting with UTI symptoms [
24]. Reports from urban and rural Rajshahi district, Bangladesh reported that 4–12% of women presenting to antenatal care had asymptomatic bacteriuria [
25,
26]. In a study of mothers at an ANC clinic in rural Nagpur, India the culture-positive UTI (symptomatic and asymptomatic) prevalence was 9.6%, similar to our study [
27]. Two studies in urban settings in northern India reported higher prevalence of ASB and UTI, ranging from 19.9% ASB prevalence in primary care clinics [
28] to 25.5% prevalence of symptomatic UTI in a tertiary care ANC clinic in Lucknow [
29].
In our pregnancy cohort, the majority of women with bacteriuria in were asymptomatic. This has relevance with respect to screening procedures in LMIC. A symptomatic approach to UTI will miss the majority of cases and the opportunity for intervention-treatment to prevent maternal morbidity and adverse pregnancy outcomes. While urine culture is standard of care in high income countries (HIC), it is typically costly and requires laboratory resources, infrastructure, and personnel and is not feasible in many LMIC settings. The diagnostic accuracy of urine dipstick and gram stain for diagnosis of ASB is poor, with particularly low sensitivity [
30,
31]. Lower cost, feasible, and accurate point of care methods/diagnostics for screening for ASB are urgently needed to improve detection and management of UTI in LMIC.
Primiparity, less paternal education, and maternal undernutrition were significant risk factors for UTI in this population. Poor hygiene practices may be more common in first time mothers of young age and those with low SES, and predispose them to urinary tract infection [
32]. Low paternal education is a marker for low SES, a frequently reported risk factor for UTI [
32]. Maternal undernutrition, defined as maternal MUAC < 23 cm, was also observed to be a risk factor for UTI in this population. Malnutrition is an important and under-recognized cause of immunodeficiency globally [
33]. Protein energy malnutrition may impair immune function (i.e. antigen-presenting cell and cell mediated T-cell function), and increase risk of maternal infections, including UTI [
34‐
36]. Undernutrition has been identified as a risk for UTI in children [
37] and the elderly [
38]. However, to our knowledge, this is the first report of this association between maternal undernutrition and UTI in a pregnancy population in a LMIC.
Gram-negative organisms,
E. coli and
Klebsiella species, were common etiologies of UTI in Sylhet, accounting for half (38 and 12%, respectively) of cases of significant bacteriuria. Other studies of UTI etiology in Bangladesh have similarly reported a predominance of gram negatives, particularly
E. coli, which comprised 59–75% of isolates, and
Klebsiella species, which ranged from 6 to 11% of isolates [
39,
40]. In a 5-year, large, prospective study of pregnant women in a tertiary care hospital in India,
E. coli and
Klebsiella pneumoniae were the most common uro-pathogens (42 and 22% of isolates, respectively) [
41].
In this population, there was also a high rate of isolation of gram-positive organisms. Specifically, staphylococcal species (non-aureus) were the second most common uro-pathogen overall, contributing to 23% of positive cultures. The majority of these isolates were presumably
Staphylococcus saprophyticus, a leading cause of cystitis in young women [
42]. However, our field laboratory did not have the capacity to further speciate with novobiocin resistance testing. Other studies in Bangladesh have reported that
S. saprophyticus [
43] comprised 11–19% of uro-pathogens [
39,
44]. In India,
S. saprophyticus comprised 10.6% of positive cultures [
45]. While
S. aureus is often considered skin flora, it accounted for 12% of cases of UTI in Sylhet. While precautions were taken to avoid skin contamination, it is difficult to ascertain whether the bacteriuria was due to skin contamination or whether it was a true uro-pathogen [
1]. Among cases of
S. aureus bacteriuria, approximately 82% were asymptomatic.
S. aureus was described as an emerging etiology of UTI in LMIC in a recent global burden review [
1]. In Nigeria,
S. aureus comprised approximately 24 to 28% of isolates in women with bacteriuria or clinical UTI [
46,
47]. A study of pregnancy-associated ASB in Sudan reported that
S. aureus comprised 39% of cases [
48]. A lower contribution of
S. aureus infection was reported in India (5.9%) [
41].
Antibiotic resistance is a growing concern, particularly in LMIC, and our study demonstrates high and concerning rates of antibiotic resistance to common antimicrobial agents for treatment of UTI in pregnancy. The gram-negative uro-pathogens were highly resistant to ampicillin and azithromycin. More than 30% of
E. coli isolates were not susceptible to common 2
nd and 3
rd generation cephalosporins. Among the most common uro-pathogens,
E. coli and staphylococcal species, there was only low-to- moderate susceptibility to cefixime, a traditionally potent oral 3
rd generation cephalosporin. Similar high and concerning rates of antibiotic resistance were reported in the WHO Global Surveillance of Antimicrobials. In national level data from South-East Asia, 16–68% of
E. coli isolates, and 34–81% of
Klebsiella isolates were resistant to 3
rd generation cephalosporins [
49,
50]. This data emphasizes the urgency for antibiotic stewardship in LMIC, and the need to also develop new effective antimicrobials with safety in pregnancy.
There were several limitations to this study. We did not have the ability to speciate coagulase-negative staphylococcal species in our field laboratory. We presume the majority of these species were Staphylococcus saprophyticus, however, it is possible that some of these may have been Staphylococcus epidermidis, which might be considered a skin contaminant. Another challenge is the differentiation of skin contamination vs. true pathogens. The rates of S. aureus growth were high, and it is difficult, if not impossible, to determine what proportion of those should be considered as UTI pathogens, particularly in asymptomatic women. While we used clean catch midstream urine specimens, the samples were collected in homes, and it is possible that some were skin contaminants. We also did not systematically collect cost data, which would have been useful to determine the cost-effectiveness of our program. There is a paucity of evidence on the cost-effectiveness of screening-treatment programs for UTI in pregnancy, which is of particular relevance in LMICs. Finally, we did not have extensive data on several known behavioral risk factors for UTI, including sexual history or toileting practices.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.